Glimepiride and Hepatitis cholestatic - a phase IV clinical study of FDA data

Summary:

Hepatitis cholestatic is reported as a side effect among people who take Glimepiride (glimepiride), especially for people who are female, 50-59 old, also take Lantus, and have Neuropathy peripheral.

The phase IV clinical study analyzes which people have Hepatitis cholestatic when taking Glimepiride. It is created by eHealthMe based on reports of 45,086 people who have side effects when taking Glimepiride from the FDA, and is updated regularly.

What is Glimepiride?

Glimepiride has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 45,909 Glimepiride users. Check the latest studies of Glimepiride.

What is Hepatitis cholestatic?

Hepatitis cholestatic (flow of bile from the liver is slowed or blocked) is found to be associated with 544 drugs and 824 conditions by eHealthMe. Check the latest studies of Hepatitis cholestatic.

On Jul, 27, 2026

45,086 people reported to have side effects when taking Glimepiride.
Among them, 13 people (0.03%) have Hepatitis cholestatic.

Could Glimepiride cause Hepatitis cholestatic?

Among these 13 people:

What is the gender of people who have Hepatitis cholestatic when taking Glimepiride? *

female: 69.23 %
male: 30.77 %

What is the age of people who have Hepatitis cholestatic when taking Glimepiride? *

What are other drugs people take besides Glimepiride? *

What are other side effects people have besides Hepatitis cholestatic? *

Cytolytic Hepatitis (dissolution or destruction of a liver cell): 3 people, 23.08%
Pancreatitis Necrotising (inflammation of the pancreas cause death of tissue in pancreas): 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Muscle Cramps (painful sensations caused by muscle contraction): 2 people, 15.38%
Itching: 2 people, 15.38%
Hepatic Failure (liver failure): 2 people, 15.38%
Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 2 people, 15.38%
Blood Bilirubin Increased: 2 people, 15.38%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 1 person, 7.69%
Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 1 person, 7.69%

What are the existing conditions these people have? *

Neuropathy Peripheral (surface nerve damage): 6 people, 46.15%
High Blood Pressure: 4 people, 30.77%
High Blood Cholesterol: 3 people, 23.08%
Prostate Cancer: 1 person, 7.69%
Pneumonia: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Glimepiride and have Hepatitis cholestatic?

- Check whether Hepatitis cholestatic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glimepiride:

Glimepiride (45,909 reports)

Browse all side effects of Glimepiride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (544 drugs)

Browse all the conditions that are associated with Hepatitis cholestatic:

Hepatitis cholestatic (824 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride (the active ingredients of Glimepiride) and Glimepiride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.